Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation

Completed · Not applicable

Conditions studied: COVID, Corona Virus Infection

In brief

The purpose of this study is to examine the impact of ascorbic acid (vitamin c) and zinc gluconate in reducing duration of symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19). Patients above the age of 18 who present to the Cleveland Clinic outpatient testing and receive a positive test for COVID-19 will be invited to participate.

Key facts

Study ID
NCT04342728
Run by
The Cleveland Clinic
People needed
214
Starts
2020-04-08
Expected to finish
2021-02-11
Last updated by the study team
2021-02-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.